Sign In
Buy BNTX
$88.45
-0.690 (-0.774%)
At Close: Jun 03, 2026
BioNTech Highlights AI Capabilities and R&D Use Cases at Inaugural AI Day
06:00am, Tuesday, 01'st Oct 2024
LONDON, United Kingdom, October 1, 2024 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”), alongside its artificial intelligence (“AI”) subsidiary InstaDeep
PFE & BNTX Get Positive CHMP Opinion for Updated COVID-19 Jab
10:56am, Monday, 23'rd Sep 2024
The Committee for Medicinal Products for Human Use recommends marketing authorization for Pfizer and BioNTech's updated version of mRNA COVID-19 jab, Comirnaty.
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union
08:11am, Friday, 20'th Sep 2024
NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced that the Committee for Medicinal Products for Human Use
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union
08:10am, Friday, 20'th Sep 2024
Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and older Data demonstrate that the Omicron KP.2-adapted COVI
BioNTech Is More Than a Covid-19 Stock. It's Having a Great September.
12:02pm, Thursday, 19'th Sep 2024
Recently BioNTech has been boosted a wave of enthusiasm over another company's cancer drug, which has turned the biopharma industry upside down.
How BioNTech, Up 25% Over Four Days, Is Riding Summit's Coattails To A Recovery
12:25pm, Tuesday, 17'th Sep 2024
BioNTech stock has climbed 25% over four days as the German biotech rides a round of cancer treatment success from Summit Therapeutics.
BioNTech to Host AI Day as an Edition of its Innovation Series on October 1, 2024
06:45am, Tuesday, 17'th Sep 2024
MAINZ, Germany, September 17, 2024 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech”), alongside its artificial intelligence (“AI”) company InstaDeep Ltd. (“InstaDeep”), will ho
Trade It or Fade It: The week's big biotech moves
06:52pm, Friday, 13'th Sep 2024
Jared Holz, Mizuho, joins 'Fast Money' to talk his playbook on recent biotech movers.
BioNTech (BNTX) Stock Jumps 5.8%: Will It Continue to Soar?
10:36am, Friday, 13'th Sep 2024
BioNTech (BNTX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength d
BioNTech's Low Valuation, Many Shots On Goal Make It A Buy
07:20am, Wednesday, 11'th Sep 2024
BioNTech shares surged 13% after Summit Therapeutics reported positive data on ivonescimab, a bispecific antibody similar to BioNTech's PM8002. BioNTech's PM8002 antibody is similar to Summit's ivones
BioNTech to Present Clinical Data Updates Across mRNA and Immunomodulatory Oncology Portfolio at ESMO Congress 2024
07:15am, Thursday, 05'th Sep 2024
MAINZ, Germany, September 05, 2024 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present clinical trial data for selected assets from its multi-platform oncology pipeline at
BioNTech BNT116 Lung Cancer mRNA Vaccine Clinical Trials Initiated
01:30pm, Sunday, 25'th Aug 2024
Currently More Than 5 Lung Cancer Vaccines Based On mRNA Platform Are Under Clinical Trials Says Kuick Research Currently More Than 5 Lung Cancer Vaccines Based On mRNA Platform Are Under Clinical Tri
Genmab: Strong H1 2024 Performance, Partner BioNTech Gives Up On Acasunlimab
11:55am, Friday, 23'rd Aug 2024
Genmab's stock continues to struggle despite the strong progress of the company's commercial portfolio in the first half of the year. Epkinly is now FDA-approved for third-line+ follicular lymphoma, w
Lung cancer patient is first in UK to receive experimental vaccine
07:29pm, Thursday, 22'nd Aug 2024
A lung cancer patient has become the first in the UK to receive a new experimental vaccine to help his body fight the disease.
Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine
02:15pm, Thursday, 22'nd Aug 2024
NEW YORK and MAINZ, GERMANY, August 22, 2024 — Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced that the U.S. Food and Drug Administration (“FDA
